GlassScriptPhysician profile
Rajesh M Dave
NPI 1184627333
$441,996.36
in general payments reported to CMS, 2019-2025
66 companies · $4,297 in 2025
The $4,297 reported for 2025 was more than what 91% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $189K · 2020: $81K · 2021: $27K · 2022: $52K · 2023: $57K · 2024: $33K · 2025: $4,297.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $58K · Travel and Lodging: $13K · Food and Beverage: $13K · Consulting Fee: $5,400 · Long Term Medical Supply Or Device Loan: $3,542.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $58,346.50 |
| Travel and Lodging | $13,337.27 |
| Food and Beverage | $13,263.02 |
| Consulting Fee | $5,400.00 |
| Long Term Medical Supply Or Device Loan | $3,541.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $93,110.83 | 2021-2025 | Verquvo |
| Abbott Laboratories | $76,908.67 | 2019-2025 | Jeti Peripheral Catheter, Optis, Jeti All In One Non-Sterile Kit |
| Chiesi USA, INC. | $53,185.71 | 2019-2025 | Kengreal, Juxtapid |
| Amgen INC. | $48,321.52 | 2019-2025 | Repatha, Repatha |
| Esperion Therapeutics, INC. | $45,003.17 | 2020-2025 | Nexletol |
| Astrazeneca Pharmaceuticals LP | $28,905.14 | 2019-2025 | Farxiga, Lokelma |
| Sanofi-Aventis U.S. LLC | $24,509.02 | 2019 | |
| Astellas Pharma US INC | $18,207.69 | 2019-2022 | |
| Novo Nordisk INC | $11,826.53 | 2023-2025 | Ozempic, Wegovy, Rybelsus |
| Angiodynamics, INC. | $8,317.12 | 2022-2025 | Auryon Laser System 100-120 Vac, Auryon Laser System 100-120 Vac |
| Cardiovascular Systems INC. | $8,263.16 | 2019-2022 | |
| Amarin Pharma, INC. | $8,110.71 | 2019-2022 | |
| Biotronik INC. | $4,462.79 | 2019-2025 | Biomonitor, Orsiro Mission, Nhancer Rx |
| Novartis Pharmaceuticals Corporation | $1,478.76 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $1,250.00 | 2019 |
Show all 60 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $903.02 | 2020-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Janssen Pharmaceuticals, INC | $865.94 | 2020-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $859.13 | 2020-2025 | Jardiance |
| Boston Scientific Corporation | $627.10 | 2019-2024 | Jetstream Sc, Ranger, Varithena Administration Pack |
| Pfizer INC. | $622.35 | 2019-2025 | |
| Reflow Medical INC | $537.43 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $524.46 | 2019-2025 | Camzyos, Eliquis |
| Cook Research Incorporated | $520.00 | 2020 | |
| Endologix LLC | $495.53 | 2025 | Endocross Device, Torus Stent Graft System |
| Actelion Pharmaceuticals US, INC. | $398.76 | 2021-2025 | Uptravi, Opsumit, Opsynvi |
| Medtronic, INC. | $371.42 | 2021-2024 | Corevalve Evolut R, Venaseal |
| Philips North America LLC | $314.96 | 2020-2024 | (Br5) Peripheral Ivus, (Br8) Peripheral Thrombectomy, (Az7) Lasers |
| Daiichi Sankyo INC. | $298.79 | 2022-2025 | Injectafer |
| Medtronic Vascular, INC. | $281.86 | 2019 | |
| Portola Pharmaceuticals, LLC | $275.76 | 2019-2020 | |
| Inari Medical, INC. | $259.50 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $223.17 | 2023-2024 | Lifevest |
| Lexicon Pharmaceuticals, INC. | $163.65 | 2023-2024 | Inpefa |
| Cordis US Corp. | $154.79 | 2022 | |
| Bard Peripheral Vascular, INC. | $148.05 | 2022-2023 | Venovo, Crosser Iq, Rotarexs 6 F X 135 Cm |
| Scpharmaceuticals INC. | $143.30 | 2025 | |
| Kiniksa Pharmaceuticals International, Plc | $116.97 | 2024 | Arcalyst |
| Bridgebio Pharma, INC. | $89.50 | 2025 | Attruby |
| Heartflow, INC. | $86.30 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $78.99 | 2021-2024 | Livalo |
| Nipro Medical Corporation | $74.33 | 2025 | Hemodialysis System |
| Impulse Dynamics (USA) INC. | $70.80 | 2023-2024 | Optimizer, Optimizer |
| Cashflow Solutions, LLC | $61.61 | 2024-2025 | Pcd-51 731a (US) - White, Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt |
| Terumo Medical Corporation | $59.56 | 2021-2022 | |
| Zoll Circulation INC | $57.96 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $52.97 | 2025 | |
| Arineta, INC | $40.28 | 2024 | Spotlight |
| Lilly USA, LLC | $40.26 | 2024-2025 | Mounjaro, Zepbound |
| Catheter Precision, INC. Fka Ra Medical Systems, INC. | $35.08 | 2019 | |
| Vivaquant INC, Dba Rhythm Express | $33.15 | 2025 | Rhythm Express |
| Glaxosmithkline, LLC. | $30.65 | 2025 | Arexvy, Shingrix |
| Inspire Medical Systems, INC. | $29.91 | 2025 | Inspire |
| Baxter Healthcare | $28.79 | 2024-2025 | Hillrom - Cardiac Ambulatory Monitor |
| Cardiva Medical, INC. | $26.85 | 2025 | Cardiva Vascade 6/7f Vcs |
| Infobionic, INC | $26.50 | 2023 | Mome Kardia |
| Penumbra, INC. | $24.93 | 2025 | Indigo System |
| Medicomp INC | $23.32 | 2024 | Telepatch Cardiac Monitor |
| Shockwave Medical, INC | $22.08 | 2022 | |
| Kestra Medical Technology Services, INC. | $20.84 | 2023 | Assure Wcd |
| Idorsia Pharmaceuticals US INC | $14.94 | 2025 | Tryvio |
6 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$21,198.50 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
$100,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rajesh Dave listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.